Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Koussounadis, Antonis ^a,d   Langdon, Simon P ^b   Um, In Hwa ^c   Harrison, David J ^c   Smith, V Anne ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN;

ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; OVARY TUMOR; PROCEDURES; XENOGRAFT;

ANIMALS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PROTEINS; RNA, MESSENGER;

EID: 84930646796     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10775     Document Type: Article

References (37)

1. de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M. & Vogel, C. Global signatures of protein and mRNA expression levels. Mol. Biosyst. 5, 1512-1526 (2009).
2. Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Gen. 13, 227-232 (2012).
3. Maier, T., Guëll, M. & Serrano, L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 583, 3966-3973 (2009).
4. Fekete, T., et al. Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples. Int. J. Cancer 131, 95-105 (2012).
5. Anderson, L. & Seilhamer, J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533-537 (1997).
6. Ideker, T. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292, 929-934 (2001).
7. Orntoft, T. F. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol. Cell. Proteomics 1, 37-45 (2001).
8. Griffin, T. J., et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 1, 323-333 (2002).
9. Greenbaum, D., Colangelo, C., Williams, K. & Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4, 117 (2003).
10. Washburn, M. P., et al. Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. P. Natl Acad. Sci. USA 100, 3107-3112 (2003).
11. Tian, Q., et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol. Cell. Proteomics 3, 960-969 (2004).
12. de Godoy, L. M. F., et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455, 1251-1254 (2008).
13. Jayapal, K. P., et al. Uncovering genes with divergent mRNA-protein dynamics in Streptomyces coelicolor. PloS ONE 3, e2097-e2097 (2008).
14. Schrimpf, S. P., et al. Comparative functional analysis of the Caenorhabditis elegans and Drosophila melanogaster proteomes. PLoS Biol. 7, e48 (2009).
15. Fournier, M. L., et al. Delayed correlation of mRNA and protein expression in rapamycin-treated cells and a role for Ggc1 in cellular sensitivity to rapamycin. Mol. Cell. Proteomics 9, 271-284 (2010).
16. Lundberg, E., et al. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Sys. Biol. 6, 450 (2010).
17. Lee, M. V., et al. A dynamic model of proteome changes reveals new roles for transcript alteration in yeast. Mol. Sys. Biol. 7, 514 (2011).
18. Maier, T., et al. Quantification of mRNA and protein and integration with protein turnover in a bacterium. Mol. Sys. Biol. 7, 511 (2011).
19. Kwon, T., Huse, H. K., Vogel, C., Whiteley, M. & Marcotte, E. M. Protein-to-mRNA ratios are conserved between Pseudomonas aeruginosa strains. J. Proteome Res. 13, 2370-2380 (2014).
20. Ly, T., et al. A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells. eLife 3, e01630 (2014).
21. Kawamoto, S., Matsumoto, Y., Mizuno, K., Okubo, K. & Matsubara, K. Expression profiles of active genes in human and mouse livers. Gene 174, 151-158 (1996).
22. Chen, G. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1, 304-313 (2002).
23. Chen, G. A., et al. Proteomic analysis of lung adenocarcinoma: Identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8, 2298-2305 (2002).
24. Fessler, M. B., Malcolm, K. C., Duncan, M. W. & Worthen, G. S. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J. Biol. Chem. 277, 31291-31302 (2002).
25. Hanash, S. M., et al. Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2, 69-75 (2002).
26. Lichtinghagen, R., et al. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur. Urol. 42, 398-406 (2002).
27. Huber, M., et al. Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogenresistant derivative T47D-r. Mol. Cell. Proteomics 3, 43-55 (2004).
28. Shankavaram, U. T., et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther. 6, 820-832 (2007).
29. Pascal, L. E., et al. Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 9, 246 (2008).
30. Vogel, C., Silva, G. M. & Marcotte, E. M. Protein expression regulation under oxidative stress. Mol. Cell. Proteomics 10, M111.009217 (2011).
31. Schwanhaüsser, B., et al. Global quantification of mammalian gene expression control. Nature 473, 337-342 (2011).
32. Koussounadis, A., Langdon, S. P., Harrison, D. J. & Smith, V. A. Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer. Brit. J. Cancer 110, 2975-2984 (2014).
33. Faratian, D., et al. Trastuzumab and pertuzumab produce changes in morphology and oestrogen receptor signalling in ovarian cancer xenografts revealing new treatment strategies. Clin. Cancer Res. 17, 4451-4461 (2011).
34. Sims, A. H., et al. Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer. Brit. J. Cancer 106, 1779-1789 (2012).
35. Miller, J. A., et al. Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics 12, 322-322 (2011).
36. Faratian, D., Um, I. H., Wilson, D. S. & Mullen, P. Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapy. Eur. J. Cancer 47, 1420-1431 (2011).
37. Smyth, G. K. Limma: linear models for microarray data. in Bioinformatics and computational biology solutions using R and Bioconductor (eds. Gentleman, R., Carey, V., Dudoit, S., Irizarry, R. & Huber, W.) 397-420 (Springer, New York, 2005).